Natco Pharma
NATCOPHARMNSE

Natco Pharma

₹1,027.5525.65 (2.56%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Livesquawk
Natco Pharma board approves 1:1 share issuance plan with Natco Crop Health Sciences. Shareholders to receive one Natco Crop Health Sciences share for each Natco Pharma share.
Livesquawk
Natco Pharma to invest up to $100K in a fully-owned subsidiary in Nigeria. The company plans to liquidate its fully-owned subsidiary in Australia.
Livesquawk
Natco Pharma launched Semaglutide generic injection in India at INR 1,290. It is 70% cheaper than pen device and 90% cheaper than the original brand.